21 hrs ago
Medifast Announces Appointment of New Independent Director
Medifast , a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss products and programs, announced today the appointment of Kevin G. Byrnes to its Board of Directors and the Company's Audit Committee, effective immediately.
Medifast Price Target Increased to $30.00 by Analysts at Canaccord Genuity
They currently have a hold rating on the stock. Several other analysts have also recently commented on the stock.
Wall St. Cheat Sheet
Earnings Volatility Drives These Stocks in a New Direction
Medifast Inc. delivered a profit and beat Wall Street's expectations, AND beat the revenue expectation.
Medifast PT Raised to $30.00 at Canaccord Genuity
The firm currently has a "hold" rating on the stock. MED has been the subject of a number of other recent research reports.
Medifast (MED) Announces Quarterly Earnings Results, Beats Expectations By $0.09 EPS
Medifast issued its quarterly earnings data on Wednesday. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.09, StockRatingsNetwork reports.